93 related articles for article (PubMed ID: 7514220)
1. Many agents that antagonize the NMDA receptor-channel complex in vivo also cause disturbances of motor coordination.
Carter AJ
J Pharmacol Exp Ther; 1994 May; 269(2):573-80. PubMed ID: 7514220
[TBL] [Abstract][Full Text] [Related]
2. Effects of the competitive N-methyl-D-aspartate antagonist CGP 37849 and its ethylester CGP 39551 on N-methyl-D-aspartate-evoked whole-cell currents in cultured spinal neurones and on vestibular stimulation-induced seizures in EL mice.
D'Hooge R; Raes A; Hiramatsu M; Mori A; Van Bogaert PP; De Deyn PP
Arzneimittelforschung; 1998 Dec; 48(12):1121-5. PubMed ID: 9893924
[TBL] [Abstract][Full Text] [Related]
3. Characterization of indole-2-carboxylate derivatives as antagonists of N-methyl-D-aspartate receptor activity at the associated glycine recognition site.
Hood WF; Gray NM; Dappen MS; Watson GB; Compton RP; Cordi AA; Lanthorn TH; Monahan JB
J Pharmacol Exp Ther; 1992 Aug; 262(2):654-60. PubMed ID: 1386886
[TBL] [Abstract][Full Text] [Related]
4. BIII 277 CL is a potent and specific ion-channel blocker of the NMDA receptor-channel complex.
Carter AJ; Bechtel WD; Grauert M; Harrison P; Merz H; Stransky W
J Pharmacol Exp Ther; 1995 Dec; 275(3):1382-9. PubMed ID: 8531106
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as antagonists of the NMDA receptor-channel complex.
Grauert M; Bechtel WD; Ensinger HA; Merz H; Carter AJ
J Med Chem; 1997 Aug; 40(18):2922-30. PubMed ID: 9288174
[TBL] [Abstract][Full Text] [Related]
6. Nociceptive behavior induced by poly-L-lysine and other basic compounds involves the spinal NMDA receptors.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Tadano T
Brain Res; 2004 May; 1008(1):49-53. PubMed ID: 15081381
[TBL] [Abstract][Full Text] [Related]
7. The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens.
Kosowski AR; Liljequist S
J Pharmacol Exp Ther; 2004 Nov; 311(2):560-7. PubMed ID: 15256539
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist.
Ferkany JW; Hamilton GS; Patch RJ; Huang Z; Borosky SA; Bednar DL; Jones BE; Zubrowski R; Willetts J; Karbon EW
J Pharmacol Exp Ther; 1993 Jan; 264(1):256-64. PubMed ID: 8423528
[TBL] [Abstract][Full Text] [Related]
9. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
[TBL] [Abstract][Full Text] [Related]
10. Sensitization to the toxic effects of cocaine in mice is associated with the regulation of N-methyl-D-aspartate receptors in the cortex.
Itzhak Y; Stein I
J Pharmacol Exp Ther; 1992 Aug; 262(2):464-70. PubMed ID: 1386882
[TBL] [Abstract][Full Text] [Related]
11. Competitive NMDA receptor antagonists and agonists: effects on spontaneous alternation in mice exposed to cerebral oligemia.
Jóźwiak L; Łukawski K; Czuczwar SJ; Sieklucka-Dziuba M
Pol J Pharmacol; 2004; 56(1):59-66. PubMed ID: 15047978
[TBL] [Abstract][Full Text] [Related]
12. Effects of N-methyl-D-aspartate receptor antagonists on carbon monoxide-induced brain damage in mice.
Ishimaru H; Katoh A; Suzuki H; Fukuta T; Kameyama T; Nabeshima T
J Pharmacol Exp Ther; 1992 Apr; 261(1):349-52. PubMed ID: 1532836
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal high-dose histamine induces spinally-mediated nociceptive behavioral responses through a polyamine site of NMDA receptors.
Watanabe C; Orito T; Watanabe H; Mizoguchi H; Yonezawa A; Yanai K; Mobarakeh JI; Onodera K; Sakurada T; Sakurada S
Eur J Pharmacol; 2008 Feb; 581(1-2):54-63. PubMed ID: 18155693
[TBL] [Abstract][Full Text] [Related]
14. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
Irifune M; Shimizu T; Nomoto M; Fukuda T
Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
[TBL] [Abstract][Full Text] [Related]
15. Effects of ifenprodil on the antidepressant-like activity of NMDA ligands in the forced swim test in mice.
Poleszak E; Wośko S; Serefko A; Szopa A; Wlaź A; Szewczyk B; Nowak G; Wlaź P
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():29-35. PubMed ID: 23774195
[TBL] [Abstract][Full Text] [Related]
16. Mouse cerebellar adenosine-glutamate interactions and modulation of ethanol-induced motor incoordination.
Dar MS
Alcohol Clin Exp Res; 2002 Sep; 26(9):1395-403. PubMed ID: 12351935
[TBL] [Abstract][Full Text] [Related]
17. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
Priestley T; Marshall GR; Hill RG; Kemp JA
Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
[TBL] [Abstract][Full Text] [Related]
18. Anticonvulsant efficacy of N-methyl-D-aspartate antagonists against convulsions induced by cocaine.
Witkin JM; Gasior M; Heifets B; Tortella FC
J Pharmacol Exp Ther; 1999 May; 289(2):703-11. PubMed ID: 10215643
[TBL] [Abstract][Full Text] [Related]
19. The dihydropyridine nitrendipine modulates N-methyl-D-aspartate receptor channel function in mammalian neurons.
Skeen GA; Twyman RE; White HS
Mol Pharmacol; 1993 Aug; 44(2):443-50. PubMed ID: 8394997
[TBL] [Abstract][Full Text] [Related]
20. Nonopioid motor effects of dynorphin A and related peptides: structure dependence and role of the N-methyl-D-aspartate receptor.
Shukla VK; Prasad JA; Lemaire S
J Pharmacol Exp Ther; 1997 Nov; 283(2):604-10. PubMed ID: 9353375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
